Medications Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases 12/13/2019 Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and Read More